Physician
Niranjan K Mittal, Physician, PLLC
Niranjan K Mittal, Physician, PLLC was paid $5.21M by Medicaid between Jan 2018 and Mar 2024, across 84 billing codes. Its largest line is 99202, Office or other outpatient visit for the evaluation and management of a new patient, straightforward — 15% of everything it billed.
33Billing provider infoNIRANJAN K MITTAL, PHYSICIAN, PLLC
BROOKLYN, NY 11209
BROOKLYN, NY 11209
33aNPI1811939465assigned 06/11/2006
33bProvider typeCardiovascular Disease Physician
28Total paid$5.21M
24GClaims98,014
24DCodes billed84
24AFirst – last monthJan 2018 – Mar 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in New York
Rank by total paid#12 of 1,564
Median peer was paid$13K
This provider vs. median400×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,545 | $1.19M | |
| 2019 | 18,170 | $931K | |
| 2020 | 25,878 | $1.04M | |
| 2021 | 26,507 | $1.07M | |
| 2022 | 13,026 | $652K | |
| 2023 | 4,557 | $308K | |
| 2024incomplete | 331 | $18K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 15% | 14,317 | 14,041 | $808K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 15,030 | 13,134 | $678K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 8.2% | 2,682 | 2,680 | $430K |
| 93970 | 7.3% | 2,832 | 2,825 | $379K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 7.1% | 1,259 | 1,258 | $369K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.1% | 8,882 | 8,231 | $321K |
| 93925 | 6.0% | 2,236 | 2,233 | $314K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.4% | 5,412 | 5,267 | $283K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.3% | 3,306 | 2,915 | $226K |
| 36478 | 3.5% | 158 | 142 | $184K | |
| 93922 | 3.3% | 2,842 | 2,835 | $174K | |
| 93015 | 2.5% | 2,084 | 2,054 | $131K |
72 more codes
| 36247 | 2.3% | 107 | $120K | |
| 93923 | 2.2% | 905 | $114K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 2.1% | 1,216 | $108K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.8% | 5,394 | $93K |
| 93880 | 1.6% | 585 | $82K | |
| 93000 | <1% | 3,965 | $46K | |
| 99401 | <1% | 2,759 | $46K | |
| 93224 | <1% | 495 | $38K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 879 | $31K |
| 36200 | <1% | 108 | $28K | |
| 93229 | <1% | 48 | $26K | |
| 75716 | <1% | 106 | $22K | |
| 75630 | <1% | 107 | $21K | |
| 36140 | <1% | 108 | $20K | |
| 93971 | <1% | 174 | $16K | |
| 93926 | <1% | 147 | $14K | |
| 86769 | <1% | 375 | $14K | |
| 99408 | <1% | 3,469 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 207 | $14K |
| 99152 | <1% | 209 | $8K | |
| 99201 | <1% | 150 | $6K | |
| 99441 | <1% | 325 | $6K | |
| 94060 | <1% | 129 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 37 | $3K |
| 90674 | <1% | 190 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,118 | $3K |
| 94729 | <1% | 141 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 233 | $2K |
| 94727 | <1% | 140 | $2K | |
| 94375 | <1% | 85 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 35 | $1K |
| 86328 | <1% | 31 | $894.35 | |
| 93228 | <1% | 49 | $875.90 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 83 | $699.68 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 112 | $660.00 |
| 81002 | <1% | 437 | $381.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 45 | $263.95 |
| 99385 | <1% | 12 | $259.53 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 22 | $259.23 |
| 3080F | <1% | 333 | $220.00 | |
| 99407 | <1% | 26 | $213.01 | |
| 3074F | <1% | 451 | $162.52 | |
| 3078F | <1% | 293 | $102.52 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 19 | $96.40 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21 | $85.76 |
| 99406 | <1% | 13 | $35.13 | |
| 1159F | <1% | 496 | $5.00 | |
| 1160F | <1% | 507 | $2.50 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 87 | $0.64 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 19 | $0.14 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 3,188 | $0.12 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,481 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 107 | $0.00 |
| 93298 | 0% | 28 | $0.00 | |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 42 | $0.00 |
| 1011F | 0% | 20 | $0.00 | |
| 3077F | 0% | 76 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 19 | $0.00 |
| 1000F | 0% | 1,196 | $0.00 | |
| 3079F | 0% | 126 | $0.00 | |
| 4086F | 0% | 48 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 149 | $0.00 |
| 1034F | 0% | 72 | $0.00 | |
| 1036F | 0% | 425 | $0.00 | |
| 3008F | 0% | 481 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 132 | $0.00 |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | 0% | 101 | $0.00 |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 0% | 28 | $0.00 |
| 99000 | 0% | 179 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 14 | $0.00 |
| 3075F | 0% | 34 | $0.00 | |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMITTAL, NIRANJAN (OWNER)